Naqid Ibrahim A
Department of Biomedical Sciences, College of Medicine, University of Zakho, Zakho Duhok, IRQ.
Cureus. 2024 Oct 17;16(10):e71671. doi: 10.7759/cureus.71671. eCollection 2024 Oct.
The COVID-19 pandemic has profoundly impacted global health, necessitating the rapid development of vaccines to reduce its effects. However, concerns among healthcare workers regarding vaccine safety and side effects have led to increased hesitancy towards COVID-19 vaccination. Therefore, this study aims to assess the severity of adverse effects and associated factors of three COVID-19 vaccines among healthcare workers in Iraqi Kurdistan.
A retrospective cross-sectional study was conducted among healthcare workers in Duhok province, Kurdistan Region, Iraq, with 625 participants aged 18 to 65 years (mean age 38.42±13.96) from August to December 2022. Data were collected through face-to-face interviews. The study questionnaire consisted of two parts: the first part collected demographic information about the participants, while the second part focused on their COVID-19 infection and vaccination status.
Of the total participants, 52.8% were female, with a mean age of 38.42 years (±13.96 SD). Approximately 67.5% received the Pfizer/BioNTech vaccine, and 60.9% had a prior history of COVID-19 infection. A significant proportion (82.24%) reported side effects, which were mostly mild or moderate, with 13.6% experiencing severe symptoms. The most commonly reported side effects across all three vaccines were pain at the injection site, fever, headache, and fatigue. Participants aged 36-50 reported significantly higher rates of severe side effects (87.88%, p = 0.047). Individuals with a history of allergies experienced significantly fewer adverse effects (48.93%) (p = 0.001). Those with prior COVID-19 infection also reported more severe symptoms post-vaccination (p = 0.001) and vaccine type-influenced side effects (p < 0.001), with Oxford/AstraZeneca recipients more likely to experience severe reactions compared to Pfizer recipients. Fatigue, chills, tremors, and myalgia were significantly more common in females than males (p < 0.005).
This study identified the most common side effects of COVID-19 vaccines among healthcare workers in Kurdistan Region of Iraq. AstraZeneca vaccine was associated with a higher prevalence of systemic effects, including fever, fatigue, headache and myalgia. These findings provide valuable insights into the safety and side effect profile of COVID-19 vaccines in the region.
新冠疫情对全球健康产生了深远影响,因此需要迅速研发疫苗以减轻其影响。然而,医护人员对疫苗安全性和副作用的担忧导致他们对新冠疫苗接种的犹豫情绪增加。因此,本研究旨在评估伊拉克库尔德斯坦地区医护人员接种三种新冠疫苗后的不良反应严重程度及相关因素。
对伊拉克库尔德斯坦地区杜胡克省的医护人员进行了一项回顾性横断面研究,研究对象为2022年8月至12月期间625名年龄在18至65岁(平均年龄38.42±13.96岁)的参与者。通过面对面访谈收集数据。研究问卷由两部分组成:第一部分收集参与者的人口统计学信息,第二部分关注他们的新冠感染和疫苗接种状况。
在所有参与者中,52.8%为女性,平均年龄为38.42岁(标准差±13.96)。约67.5%的人接种了辉瑞/生物科技公司的疫苗,60.9%的人有新冠感染史。相当一部分人(82.24%)报告有副作用,大多为轻度或中度,13.6%出现严重症状。所有三种疫苗最常报告的副作用是注射部位疼痛、发热、头痛和疲劳。年龄在36至50岁的参与者报告的严重副作用发生率显著更高(87.88%,p = 0.047)。有过敏史的个体出现不良反应的情况明显较少(48.93%)(p = 0.001)。有新冠感染史的人在接种疫苗后也报告有更严重的症状(p = 0.001)以及疫苗类型影响副作用(p < 0.001),与辉瑞疫苗接种者相比,接种牛津/阿斯利康疫苗的人更有可能出现严重反应。疲劳、寒战、震颤和肌痛在女性中比男性更常见(p < 0.005)。
本研究确定了伊拉克库尔德斯坦地区医护人员接种新冠疫苗后最常见的副作用。阿斯利康疫苗与包括发热、疲劳、头痛和肌痛在内的全身效应较高发生率相关。这些发现为该地区新冠疫苗的安全性和副作用情况提供了有价值的见解。